Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 30, 2003

View Archived Issues

Shire BioChem scientists report new agents for hepatitis C virus

Novel antifungal macrolides isolated and tested by Ajinomoto scientists

Calcium antagonists and their use in IBS reported by Ajinomoto

Ono identifies novel cysteine protease inhibitors

Boehringer Ingelheim claims new cathepsin inhibitors for osteoporosis, arthritis, etc.

HMG-CoA-inhibitory simvastatin analogues covered by Ranbaxy patent

New CRF1 receptor modulators and their use in anxiety, depression and bowel disorders

Allosteric AMPA modulators discovered by Boehringer Ingelheim researchers

Phase II Liprostin study cleared to begin

GTx and Wyeth enter agreement for VSV-based therapeutics and vaccines

Genome Therapeutics and MerLion form antiinfective drug discovery collaboration

Solvay and Innogenetics extend research collaboration

Epicyte advances production of human HIV antibodies in plants

NicOx and Biolipox expand research on NO-donating respiratory drugs

Tarceva phase III trial in pancreatic cancer achieves target enrollment

AlphaRx acquires exclusive rights to VT-1

Alliance and Baxter to restructure Oxygent agreement

High-affinity sigma receptor ligand SSR-125392A effective in animal models of GVHD and RA

Ref-1/AP-1 validated as therapeutic target for asthma in recent PNAS article

FDA issues complete response letter for Aldurazyme

U.S. phase II trial of antibody targeting IL-15 cleared

First clinical study of IPL-512602 under way in the U.S.

Second filing announced for YM-905

Amylin acquires rights to GLP-1 program from Restoragen

Triangle now part of Gilead

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...